Latest on Multiple Myeloma - Part 4: Importance of Clinical Trials

Jesus Berdeja, M.D.

Latest on Multiple Myeloma - Part 4: Importance of Clinical Trials

Jesus Berdeja, M.D., Director of Multiple Myeloma Research at Sarah Cannon Research Institute discusses multiple myeloma and the importance of clinical trials in part 4 of our video series, The Latest on Multiple Myeloma.